Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paloma Sangro

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|August 20, 2025
Tremelimumab for the treatment of hepatocellular carcinomaMiguel Sogbe, Paloma Sangro, Manuel de la Torre-Aláez, et al.
Revista Espanola De Enfermedades Digestivas|June 15, 2022
Immunotherapy in hepatocellular carcinomaManuel de la Torre, Paloma Sangro, Delia D Avola, et al.
Journal of Physiology and Biochemistry|March 28, 2023
Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatmentPaloma Sangro, Manuel de la Torre Aláez, Bruno Sangro, et al.
Cancers|June 2, 2021
The Landscape of lncRNAs in Hepatocellular Carcinoma: A Translational PerspectiveJuan Pablo Unfried, Paloma Sangro, Laura Prats-Mari, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2017
Intracavitary and Systemic Daptomycin for Successful Treatment of a Postpneumonectomy Intrathoracic InfectionPaloma Sangro, Francisco Carmona-Torre, Miguel Mesa, et al.
Carcinogenesis|November 16, 2024
Prognostic value of circulating tumor DNA in different cancer types detected by ultra-low-pass whole-genome sequencing: a systematic review and patient-level survival data meta-analysisMiguel Sogbe, Daniel Aliseda, Paloma Sangro, et al.
Oncotarget|February 22, 2018
Pneumatocele during sorafenib therapy: first report of an unusual complicationPaloma Sangro, Idoia Bilbao, Nerea Fernández-Ros, et al.
Cancers|September 13, 2025
Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next?Lucía Ceniceros, Manuel de La Torre, Ana Landa Magdalena, et al.
Cancer Research|August 8, 2019
Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy TissuesJuan P Unfried, Guillermo Serrano, Beatriz Suárez, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 14, 2018
Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substageAlberta Cappelli, Paloma Sangro, Cristina Mosconi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|August 20, 2025
Tremelimumab for the treatment of hepatocellular carcinomaMiguel Sogbe, Paloma Sangro, Manuel de la Torre-Aláez, et al.
Revista Espanola De Enfermedades Digestivas|June 15, 2022
Immunotherapy in hepatocellular carcinomaManuel de la Torre, Paloma Sangro, Delia D Avola, et al.
Journal of Physiology and Biochemistry|March 28, 2023
Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatmentPaloma Sangro, Manuel de la Torre Aláez, Bruno Sangro, et al.
Cancers|June 2, 2021
The Landscape of lncRNAs in Hepatocellular Carcinoma: A Translational PerspectiveJuan Pablo Unfried, Paloma Sangro, Laura Prats-Mari, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2017
Intracavitary and Systemic Daptomycin for Successful Treatment of a Postpneumonectomy Intrathoracic InfectionPaloma Sangro, Francisco Carmona-Torre, Miguel Mesa, et al.
Carcinogenesis|November 16, 2024
Prognostic value of circulating tumor DNA in different cancer types detected by ultra-low-pass whole-genome sequencing: a systematic review and patient-level survival data meta-analysisMiguel Sogbe, Daniel Aliseda, Paloma Sangro, et al.
Oncotarget|February 22, 2018
Pneumatocele during sorafenib therapy: first report of an unusual complicationPaloma Sangro, Idoia Bilbao, Nerea Fernández-Ros, et al.
Cancers|September 13, 2025
Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next?Lucía Ceniceros, Manuel de La Torre, Ana Landa Magdalena, et al.
Cancer Research|August 8, 2019
Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy TissuesJuan P Unfried, Guillermo Serrano, Beatriz Suárez, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 14, 2018
Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substageAlberta Cappelli, Paloma Sangro, Cristina Mosconi, et al.
Pageof 2